valuation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test

Objectives: The aim of this study was to evaluate subclinical multiple sclerosis (MS) patients with normal visual acuity using pattern visual evoked potentials (PVEP) test and central 30-2 threshold visual field (VF) test. Materials and Methods: A total of 60 patients, 30 of which had a definitive...

Full description

Bibliographic Details
Main Authors: Sinan Bilgin, Süleyman Sami İlker, Ercüment Çavdar
Format: Article
Language:English
Published: Galenos Yayinevi 2014-05-01
Series:Türk Oftalmoloji Dergisi
Subjects:
Online Access:http://www.oftalmoloji.org/article_6093/Evaluation-Of-Subclinical-Multiple-Sclerosis-Patients-Using-Pattern-Visual-Evoked-Potentials-And-Visual-Field-Test
_version_ 1797913162578657280
author Sinan Bilgin
Süleyman Sami İlker
Ercüment Çavdar
author_facet Sinan Bilgin
Süleyman Sami İlker
Ercüment Çavdar
author_sort Sinan Bilgin
collection DOAJ
description Objectives: The aim of this study was to evaluate subclinical multiple sclerosis (MS) patients with normal visual acuity using pattern visual evoked potentials (PVEP) test and central 30-2 threshold visual field (VF) test. Materials and Methods: A total of 60 patients, 30 of which had a definitive MS diagnosis and 30 who were healthy volunteers, were included in the study. The participants were divided into the following three groups: Group 1 - optic neuritis (+) MS patients, Group 2 - optic neuritis (-) MS patients, and Group 3 - control group. Using white on white perimetry, SITA FAST central 30-2 threshold VF tests and 1˚-0.3˚ PVEP measurements were performed. MD, PSD, p100 latency (ms), p100 amplitude (µV), and central 0-10˚, 0-20˚, 0-30˚, 10-20˚, 10-30˚, 20-30˚ retina sensitivities (db) were evaluated in all groups. Results: There was a significant difference in all parameters between Group 1 and Group 3 (p<0.05). There was a significant difference in p100 latency 1˚- 0.3˚, p100 amplitude 0.3˚, central 0-30˚, 10-30˚, 20-30˚ between Group 2 and Group 3 (p<0.05). There was no significant difference in the parameters except for p100 amplitude 1˚ between Group 1 and Group 2 (p>0.05). Conclusion: The evaluation of PVEP and central 30˚ VF can be used to monitor disease prognosis in subclinical MS patients. (Turk J Ophthalmol 2014; 44: 207-11)
first_indexed 2024-04-10T12:08:37Z
format Article
id doaj.art-f1489939d2ef4ce7aa0a43887877e5e1
institution Directory Open Access Journal
issn 1300-0659
2147-2661
language English
last_indexed 2024-04-10T12:08:37Z
publishDate 2014-05-01
publisher Galenos Yayinevi
record_format Article
series Türk Oftalmoloji Dergisi
spelling doaj.art-f1489939d2ef4ce7aa0a43887877e5e12023-02-15T16:16:08ZengGalenos YayineviTürk Oftalmoloji Dergisi1300-06592147-26612014-05-0144320721110.4274/tjo.75983valuation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field TestSinan Bilgin0 Süleyman Sami İlker1Ercüment Çavdar2Celal Bayar Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Manisa, TürkiyeCelal Bayar Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Manisa, TürkiyeKemal Paşa Devlet Hastanesi, Göz Hastalıkları Kliniği, İzmir, TürkiyeObjectives: The aim of this study was to evaluate subclinical multiple sclerosis (MS) patients with normal visual acuity using pattern visual evoked potentials (PVEP) test and central 30-2 threshold visual field (VF) test. Materials and Methods: A total of 60 patients, 30 of which had a definitive MS diagnosis and 30 who were healthy volunteers, were included in the study. The participants were divided into the following three groups: Group 1 - optic neuritis (+) MS patients, Group 2 - optic neuritis (-) MS patients, and Group 3 - control group. Using white on white perimetry, SITA FAST central 30-2 threshold VF tests and 1˚-0.3˚ PVEP measurements were performed. MD, PSD, p100 latency (ms), p100 amplitude (µV), and central 0-10˚, 0-20˚, 0-30˚, 10-20˚, 10-30˚, 20-30˚ retina sensitivities (db) were evaluated in all groups. Results: There was a significant difference in all parameters between Group 1 and Group 3 (p<0.05). There was a significant difference in p100 latency 1˚- 0.3˚, p100 amplitude 0.3˚, central 0-30˚, 10-30˚, 20-30˚ between Group 2 and Group 3 (p<0.05). There was no significant difference in the parameters except for p100 amplitude 1˚ between Group 1 and Group 2 (p>0.05). Conclusion: The evaluation of PVEP and central 30˚ VF can be used to monitor disease prognosis in subclinical MS patients. (Turk J Ophthalmol 2014; 44: 207-11)http://www.oftalmoloji.org/article_6093/Evaluation-Of-Subclinical-Multiple-Sclerosis-Patients-Using-Pattern-Visual-Evoked-Potentials-And-Visual-Field-TestPattern visual evoked potentialsvisual fieldmultiple sclerosis
spellingShingle Sinan Bilgin
Süleyman Sami İlker
Ercüment Çavdar
valuation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test
Türk Oftalmoloji Dergisi
Pattern visual evoked potentials
visual field
multiple sclerosis
title valuation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test
title_full valuation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test
title_fullStr valuation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test
title_full_unstemmed valuation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test
title_short valuation of Subclinical Multiple Sclerosis Patients Using Pattern Visual Evoked Potentials and Visual Field Test
title_sort valuation of subclinical multiple sclerosis patients using pattern visual evoked potentials and visual field test
topic Pattern visual evoked potentials
visual field
multiple sclerosis
url http://www.oftalmoloji.org/article_6093/Evaluation-Of-Subclinical-Multiple-Sclerosis-Patients-Using-Pattern-Visual-Evoked-Potentials-And-Visual-Field-Test
work_keys_str_mv AT sinanbilgin valuationofsubclinicalmultiplesclerosispatientsusingpatternvisualevokedpotentialsandvisualfieldtest
AT suleymansamiilker valuationofsubclinicalmultiplesclerosispatientsusingpatternvisualevokedpotentialsandvisualfieldtest
AT ercumentcavdar valuationofsubclinicalmultiplesclerosispatientsusingpatternvisualevokedpotentialsandvisualfieldtest